drugset
drugset / Trial / NCT06366672

Evaluating the Human Immune Response to the JYNNEOS Vaccine

NCT06366672 ↗

Phase 0 Active not recruiting 20 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelBasic science

Summary

This study is designed to evaluate the magnitude and duration of the human adaptive immune response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine in the blood, lung mucosa, skin and bone marrow.

Timeline

Start
2024-06-10
Primary completion
2026-09
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject IMVAMUNE Vaccine — Subcutaneous

Indications

vaccinia